Designed jointly by EHDEN and OHDSI, the Data Quality Dashboard (DQD) debuted last August with the National COVID Cohort Collaborative, which is an initiative funded by the United States National Institutes of Health (NIH). The NIH is the largest biomedical research agency in the world and is part of the United States Department of Health … Read more
We are pleased to announce that we’ve just launched the next course in the EHDEN Academy, teaching you deeper insights into phenotype definition, characterisation and evaluation, using ATLAS, Cohort Diagnostics and the PheValuator tool. This is a fundamental aspect of the OHDSI framework for conducting observational research. In a stepwise approach, you will be guided … Read more
Hospitalized COVID-19 Patients Shown To Be Younger, Healthier Than Influenza Patients Per Recent Global Observational Health Study Patients hospitalized with COVID-19 were more likely male, younger and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published recently by the Observational Health … Read more
Last week, September 22-23, we had a second training and certification meeting for the SMEs that were selected in our Second open call for SMEs. During these 2 days, another 5 SMEs were certified by EHDEN for their knowledge on standardising health data to the OMOP common data model and the installation of the technical … Read more
15 September 2020, Brussels, Belgium: The EHDEN Consortium would like to invite all data custodians of Electronic Health Records, Claims, Hospital and Registry data across Europe to participate in its open call, supporting the mapping of their data to the OMOP common data model. The ambitions of the EHDEN project are high as we aim … Read more
An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, … Read more
On the 4th and 5th of August, EHDEN organised a virtual certification meeting, inviting a first group of 10 European SMEs out of the 15 that were selected during our open call for SMEs in February. During these 2 days, these SMEs were certified by EHDEN for their knowledge on standardising health data to the … Read more
We are pleased to announce that we’ve just launched a new course in the EHDEN Academy, teaching you how to use the ATLAS toolset. ATLAS is a free, publicly available web-based, open-source software application developed by the OHDSI community. ATLAS supports the design and execution of analyses across one or more observational databases which have … Read more
28 July 2020, Brussels, Belgium. Healthcare today is ever more complex, with growing expectations from our advancing insights into our own biology, diseases, their diagnosis, treatment and outcomes, and innovation in those treatments. Working within individual institutions to generate insights in the 21st century is much more challenging, hence collaboration, and at scale across multiple … Read more
22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more